Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMA: Liquid Biopsies and Imaging in Rectal Cancer
NCT04224779Active, not recruiting
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Feb 2021
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut du Cancer de Montpellier. Primary endpoint: Area under the Receiver Operating Characteristic (ROC) curve of total cfDNA percent change between baseline (T1) and end of NAT (T3). Started Feb 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04224779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224779.